H. Lundbeck A/S (HLUYY) Stock Analysis
DELISTED
What happened to H. Lundbeck A/S (HLUYY) stock?
H. Lundbeck A/S (HLUYY) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
P/E 11.40 means the share price is 11.40 times one year of earnings per share.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
H. Lundbeck A/S (HLUYY). H. Lundbeck A/S is a biopharmaceutical company focused on researching, developing, and marketing pharmaceuticals for psychiatric and neurological disorders.
Last analyzed: Mar 18, 2026H. Lundbeck A/S (HLUYY) Healthcare & Pipeline Overview
H. Lundbeck A/S ADR Information Unsponsored
H. Lundbeck A/S (HLUYY) trades in the U.S. as an American Depositary Receipt (ADR).
- ADR Level: 1
- ADR Ratio: 1:1
- Home Market Ticker: HLUY
HLUYY OTC Market Information
HLUYY trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy HLUYY shares?
No. HLUYY stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for HLUYY elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before HLUYY stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to H. Lundbeck A/S. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.